Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Acta Biomater. 2011 Sep;7(9):3488-95. doi: 10.1016/j.actbio.2011.05.025. Epub 2011 May 27.
Titanium alloys are prevalently used as orthopedic prosthetics. Inadequate bone-implant interactions can lead to premature prosthetic loosening and implant failure. Local delivery of osteogenic therapeutics promoting osteointegration of the implant is an attractive strategy to address this clinical challenge. Given the affinity of calcium apatites for bone matrix proteins we hypothesize that titanium alloys surface mineralized with calcium apatites should be explored for the retention and local delivery of osteogenic recombinant human bone morphogenetic protein-2 (rhBMP-2). Using a heterogeneous surface nucleation and growth process driven by the gradual pH elevation of an acidic solution of hydroxyapatite via thermal decomposition of urea, Ti6Al4V substrates were surface mineralized with calcium apatite domains exhibiting good affinity for the substrate. The microstructures, size and surface coverage of the mineral domains as a function of the in vitro mineralization conditions were examined by light and scanning electron microscopy and the surface calcium ion content quantified. An optimal mineralization condition was identified to rapidly (<10h) achieve surface mineral coverage far superior to those accomplished by week long incubation in simulated body fluids. In vitro retention-release profiles of rhBMP-2 from the mineralized and unmineralized Ti6Al4V, determined by an enzyme-linked immunosorbent assay, supported a higher degree of retention of rhBMP-2 on the mineralized substrate. The rhBMP-2 retained on the mineralized substrate after 24h incubation in phosphate-buffered saline remained bioactive, as indicated by its ability to induce osteogenic transdifferentiation of C2C12 myoblasts attached to the substrate. This mineralization technique could also be applied to the surface mineralization of calcium apatites on dense tantalum and titanium and porous titanium substrates.
钛合金被广泛用作矫形假体。骨-植入物相互作用不足会导致假体过早松动和植入物失效。局部递送促进植入物骨整合的成骨治疗剂是解决这一临床挑战的一种有吸引力的策略。鉴于钙磷灰石对骨基质蛋白的亲和力,我们假设应该探索用钙磷灰石对钛合金表面进行矿化处理,以保留和局部递送成骨重组人骨形态发生蛋白-2(rhBMP-2)。通过热分解尿素使酸性溶液的 pH 逐渐升高来驱动非均匀表面成核和生长过程,Ti6Al4V 基底用具有良好基底亲和力的钙磷灰石畴进行表面矿化。用光镜和扫描电子显微镜以及表面钙离子含量的定量分析研究了微结构、大小和矿化域的表面覆盖率作为体外矿化条件的函数。确定了最佳矿化条件,可在短时间(<10h)内实现表面矿化覆盖率,远远超过在模拟体液中孵育一周所达到的覆盖率。通过酶联免疫吸附试验测定,从矿化和未矿化 Ti6Al4V 上保留的 rhBMP-2 的体外保留-释放曲线表明,rhBMP-2 在矿化基底上的保留程度更高。在磷酸盐缓冲盐水孵育 24 小时后保留在矿化基质上的 rhBMP-2 仍然具有生物活性,这表明其能够诱导附着在基质上的 C2C12 成肌细胞的成骨分化。该矿化技术也可应用于致密钽和钛以及多孔钛基底上钙磷灰石的表面矿化。